
|

| |
Track this member and follow
their portfolio moves with tickerspy™ alerts |
 |
|
cooper
Portfolio List (2): |
drugs delivery
|
| |
Performance |
|
|
|
Ideas |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
+2.6%
+1.1%
-1.4%
+146.2%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+2.7%
+2.0%
-5.7%
+67.0%
|
|
|
|
|
|
|
|
|
Share this portfolio on Facebook
Share this portfolio on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ALKS |
$32.84 |
-0.16 |
-0.5% |
2,174,934 |
125% |
$4.3B |
- |
122% |
-1% |
+281.4% |
2 Alerts (0 News) - View
|
|
|
| CBRX |
$0.62 |
0.00 |
-0.2% |
182,357 |
59% |
$54.1M |
- |
12% |
-50% |
-51.3% |
No Alerts/News
|
|
|
| DRRX |
$0.85 |
-0.04 |
-4.2% |
105,769 |
12% |
$86.9M |
- |
40% |
-54% |
-63.5% |
No Alerts/News
|
|
|
| FLML |
$4.66 |
+0.04 |
+0.9% |
38,138 |
74% |
$116.3M |
- |
64% |
-17% |
-25.0% |
No Alerts/News
|
|
|
| HSP |
$35.08 |
-0.10 |
-0.3% |
518,587 |
39% |
$5.8B |
- |
23% |
-7% |
+2.2% |
1 Alert (1 News) - View
|
|
|
| KVPHQ |
$0.10 |
0.00 |
+4.6% |
121,142 |
103% |
$6.2M |
- |
304% |
-93% |
-93.8% |
No Alerts/News
|
|
|
| NKTR |
$9.27 |
-0.04 |
-0.4% |
929,055 |
88% |
$1.0B |
- |
64% |
-18% |
+43.1% |
1 Alert (0 News) - View
|
|
|
| [NOVN] |
$0.00 |
0.00 |
0.0% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
No Alerts/News
|
|
|
| [PPCO] |
$0.00 |
0.00 |
0.0% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
No Alerts/News
|
|
|
| VRX |
$84.47 |
+9.80 |
+13.1% |
10,383,614 |
839% |
$25.6B |
- |
99% |
7% |
+610.4% |
8 Alerts (3 News) - View
|
|
|
|
|
Discuss this portfolio with cooper
|
|
|
|
| |

|
| |
|
| |

|
| |
Warburg Would Reap Threefold Return in Bausch Transaction ACT VRX
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 24, 06:43PM from (www.bloomberg.com) Warburg Pincus LLC would reap more than a threefold return on its $1.7 billion equity investment in Bausch & Lomb
Flag
Post a comment
Bausch & Lomb Unit Pays $33.5 Million in Misbranding Case VRX
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 24, 05:28PM from (www.bloomberg.com) Ista Pharmaceuticals Inc., a unit of Bausch & Lomb Inc. that makes medicine to treat eye ailments, agreed to pay
Flag
Post a comment
DealBook: Bausch & Lomb Said to Be Near $9 Billion Sale to Valeant VRX
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 24, 12:56PM from (dealbook.nytimes.com) If completed, a transaction would be one of the biggest health care deals of the year. And it could reap a sizable profit
Flag
Post a comment
Wockhardt Drug Filings Seen Delayed After U.S. FDA Alert HSP
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 24, 08:33AM from (www.bloomberg.com) Wockhardt Ltd. (WPL), an Indian maker of insulin and hepatitis vaccines, will not win new drug approvals this year for about
Flag
Post a comment
Pharma M&A – Actavis to Acquire Warner Chilcott FRX MYL TEVA ACT VRX WCRX
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 20, 11:32AM from (www.benzinga.com) On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner
Flag
Post a comment
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal MYL VRX WCRX
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 20, 08:16AM from (dealbook.nytimes.com) Actavis, a maker of generic drugs, agreed to buy the specialty pharmaceutical company Warner Chilcott for about $5 billion
Flag
Post a comment
'Love Hormone' Promises Safer Births After Pfizer Flop PFE MNKD NKTR
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 19, 06:03PM from (www.bloomberg.com) A hormone treatment based on technology used in Pfizer Inc. (PFE)’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
Flag
Post a comment
Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 ALKS
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 04:00PM from (www.businesswire.com) Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:00 a.m. EDT (1:00 p.m. BST) on Thursday, May 23, 2013, to discuss
Flag
Post a comment
Alkermes Elects Nancy Wysenski to Board of Directors ALKS
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 07:00AM from (www.businesswire.com) Alkermes plc (NASDAQ: ALKS) today announced the election of Nancy J. Wysenski to the company’s Board of Directors. Most
Flag
Post a comment
What We're Reading ~ Analytical Links 5/15/13 VZ VOD DLTR HSP FLT
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 15, 01:05PM from (www.marketfolly.com) Meb Faber's new book: Shareholder Yield [Meb Faber]
Explanation of Tepper's chart: Equity risk premium is high (this is bullish) [The Big Picture]
Flag
Post a comment
Michael Price's Presentation at London Value Conference: Long Hospira & Hess HES HSP BRK.A
Linked by market folly ( track newsfeed | ignore newsfeed ) - May 13, 01:52PM from (www.marketfolly.com) Continuing our notes from the London Value Investor Conference 2013, the next speaker is Michael Price of MFP Investors.
Flag
Post a comment
Hospira Sues B. Braun Over Infusion-Pump System Patents HSP
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 09, 11:09AM from (www.bloomberg.com) Hospira Inc. (HSP), a maker of acute-care products, sued a U.S. unit of Germany’s B. Braun Melsungen AG alleging infringement of patents for drug-infusion pump technology.
Flag
Post a comment
ICU Said to Explore Sale That May Fetch $1 Billion JPM ICUI HSP
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 08, 01:10PM from (www.bloomberg.com) ICU Medical Inc. (ICUI), the San Clemente, California-based producer of intravenous medical equipment, is weighing a sale
Flag
Post a comment
|
|